INDBInternet News Database 2.5 Updated 1 min ago · 282 sources Show or hide images Light or dark

Results for “Clinical Research Facility”

1 source

Who is covering this

OxfordmailCenter
Truth score 38
Centre 100%100%
OxfordmailCenter

Oxford psilocybin depression study reaches final participant milestone

The final participant has completed their last visit in the COMP006 study at Oxford, marking the end of the active delivery phase at the NIHR Clinical Research Facility (CRF).

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 100Sensationalism: 0 Amplification: 0

How we score

Analyze: Compare coverage
Like
Business
2 sources

Who is covering this

IbtimesCenterRedditLeans left
Truth score 50Factuality: Mixed
Left 50%50%Centre 50%50%
IbtimesCenter

Who Is Larissa Portnoff? Clinical Psychologist Claims She Was 'One of the Child Victims of Donald Trump'

Larissa Portnoff's academic background, clinical role and allegations against Donald Trump examined. Her claims remain unverified.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom50%
United States50%
Media ownership
Independent100%
Avg reliability58
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 50 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 58 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Sports
2 sources

Who is covering this

BBC NewsCenterThe GuardianLeft
Truth score 61
Left 50%50%Centre 50%50%
BBC NewsCenter

Clinical Man City edge past London City in WSL thriller

Manchester City earn a dramatic victory courtesy of goals from Khadija Shaw and Lauren Hemp against an excellent but wasteful London City Lionesses side.

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: Public broadcasterOwner: BBC (UK Government)
+ 1 · Full coverage
Coverage breakdown
Funding
Public broadcaster50%
Nonprofit trust50%
Countries
United Kingdom100%
Media ownership
Scott Trust50%
BBC (UK Government)50%
Avg reliability88
Low-credibility share0%
Fact / opinion3/0
State media0%
More analysis
Truth score: 61 (Corroborated) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 88 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 2 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Can Technology Restore Sight? A Clinical Update

A retinal implant may offer selected patients with geographic atrophy limited form vision, while gene-based and cortical approaches remain at earlier stages of testing. Medscape News Europe

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Business
1 source

Who is covering this

NewsCenter
Truth score 38
Centre 100%100%
NewsCenter

Stronger cholesterol treatment shrinks more plaque in heart arteries, new clinical trial finds

Stronger cholesterol treatment shrinks more plaque in heart arteries, new clinical trial finds Medical Xpress

Lean: Center Fact-focusedFactuality: Mostly factualCountry: IndiaFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Compare coverage
Like
Business
1 source

Who is covering this

NewsCenter
Truth score 38
Centre 100%100%
NewsCenter

Experts discuss pros, cons of psychedelics for recreational, clinical purposes

Experts discuss pros, cons of psychedelics for recreational, clinical purposes American Public Health Association Opinion | Could My Patients Benefit From Psychedelics? The New York Times Can Psychedelics Restore Consciousness? The...

Lean: Center Fact-focusedFactuality: Mostly factualCountry: IndiaFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Story Timeline
Like
Business
1 source

Who is covering this

NewsCenter
Truth score 38
Centre 100%100%
NewsCenter

Endovascular thrombectomy for acute ischemic stroke with large infarct core: translating results from a randomized trial into clinical practice

Endovascular thrombectomy for acute ischemic stroke with large infarct core: translating results from a randomized trial into clinical practice Annals of Translational Medicine

Lean: Center Fact-focusedFactuality: Mostly factualCountry: IndiaFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Science
1 source

Who is covering this

PhysCenter
Truth score 38
Centre 100%100%
PhysCenter

Boat burial reveals leprosy strain in fifth-century Germany

Visigothic and Vandal forces marched into Italy and conquered Rome; the Huns spread fear and terror on their campaigns through Western Europe; the Franks expanded their domain southward—the fifth century was an era of profound, often...

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Health
3 sources

Who is covering this

euronews (English)CenterAl Jazeera EnglishLeans leftGlobal IssuesLeans left
Truth score 591
Left 67%67%Centre 33%33%
euronews (English)Center

Ebola kills over 5,300 in fastest-growing outbreak on record

The Bundibugyo strain has spread to Kenya and Uganda, while two in Nigeria returned negative results. Covered by 3 outlets: 2 lean left, 1 are centre.

Lean: Center VideoFactuality: HighCountry: FranceFunding: CorporateOwner: Alpac Capital
  • Global Issues Two new Ebola vaccines to join DR Congo clinical trial

    Two new Ebola vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo (DRC) as the country continues to battle a deadly outbreak caused by the Bundibugyo species of the virus....

    Lean: Leans left Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: Nonprofit
  • Al Jazeera English WHO approves trials for two new Ebola vaccines

    Two new vaccines were designed for the Bundibugyo virus that has killed more than 5,300 in the DR Congo.

    State-funded media
    Lean: Leans left Fact-focusedFactuality: HighCountry: QatarFunding: State-fundedOwner: Qatar GovernmentState media
+ 1 · Full coverage
Coverage breakdown
Funding
Corporate33%
State-funded33%
Nonprofit33%
Countries
France33%
Qatar33%
United States33%
Media ownership
Alpac Capital33%
Qatar Government33%
Global Issues33%
Avg reliability75
Low-credibility share0%
Fact / opinion4/0
State media33%
More analysis
Truth score: 59 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 3 Reliability: 75 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Story Timeline
Like